You are here: Home / Infrastructures / Res. Infrastructure
National Center for Infectious Diseases Models and Innovative Therapies (IDMIT)
Hosting Legal Entity
French Alternative Energies and Atomic Energy Commission
Gif-sur-yvette cedex, PO: 91191 (Undefined)
18 Route du Panorama, CEA/MIRCen Bat 61, Fontenay aux Roses, PO: 92265 (France)
Type Of RI
Coordinating Country
Current Status:
Operational since 2012
Under construction to 2017
Scientific Description
The research center for 'Infectious Disease Models and Innovative Therapies' (IDMIT) at the CEA site, in Fontenay-aux-Roses was created by the Life Sciences Division of the CEA, the Institut Pasteur, the 'Institut National de la Santé et de la Recherche Médicale' (INSERM), the 'Agence Nationale de Recherche sur le SIDA et les Hépatites Virales' (ANRS), Université Paris Sud 11 (UPS-11) and Bertin Pharma. The center is dedicated to preclinical research programs on human vaccines and antimicrobial treatments. It is equipped with state-of-the-art facilities for animal studies and in vitro assays. The infrastructure also develops advanced technologies for monitoring infections and host responses, including in vivo imaging in BSL3 containment (near infra-red fluorescence, confocal endo-microscopy, two-photon microscopy, PET-CT) and complex cell phenotyping (CyTof). The center is targeted at the academic and industrial scientific communities.

RI Keywords
Vaccines, Therapy, Infectious diseases, Animal models, Non-human primates, In vivo imaging, Immunomonitoring
RI Category
Cell Culture Facilities
Safety Handling facilities
Collections of Biological Resources (e.g. Microorganisms, Biobanks and Seed Banks)
Genomic, Transcriptomic, Proteomics and Metabolomics Facilities
Reference material repositories
Biomedical Imaging Facilities
Translational Research Centres
Animal facilities
Scientific Domain
Biological and Medical Sciences
ESFRI Domain
Health and Food
Mass Cytometry
In Vivo Imaging, Animal Studies

Biodistribution studies.

Flow Cytometry
Animal Studies

Pharmacodynamics, pharmacokinetics, pathogenesis


Immunogenicity, immuno-safety, challenge studies.

Flow cytometry, cell-sorting, mass-cytometry, in vivo imaging, BSL2 and BSL3 labs and animal facilities

Cytometry analysers, cell-sorting suite in BSL3, Cytof, in-vivo imaging for living animals in BSL2 and BSL3.

Date of last update: 19/03/2019
Printable version